Specialty medications are used to treat complex medical conditions and usually require injection and special handling. PEBTF members have access to the CVS Specialty CareTeam to provide personalized support.
As of April 1, the CVS formulary now includes biosimilars for the brand-name Humira.
So, what exactly ARE biosimilars?
A biosimilar is an FDA approved medicine that has been developed to be highly similar to the original biologic reference product and has no clinically meaningful differences compared to it. Biosimilars work the same way as the original biologic reference product by creating a similar response in your body. They are taken the same way and have the same possible side effects.
Biosimilars are not a new concept and have been available and used successfully for years. Biosimilars may be more cost effective for you and provide greater access to biologic and biosimilar treatment options. When there is more than one medication available to treat a condition, pricing usually becomes more competitive. CVS Specialty works to keep costs the same or less for you as you are making this transition.
The CVS Specialty CareTeam is ready to assist you with all of your biosimilar needs, from injection training and nursing to connecting you with needs-based and non-needs-based financial assistance programs. CVS will also work with your health care provider to obtain a new biosimilar prescription.
For more information, visit: https://www.cvsspecialty.com/resource-center/biosimilars/101-patient-video.html
